Gene and protein expression profiles of JAK-STAT signalling pathway in the developing brain of the Ts1Cje down syndrome mouse model

References

• Antonarakis SE, Lyle R, Dermitzakis ET, et al. Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet. 2004;5:725–738.
   PubMed Web of Science ®Google Scholar
• Pritchard MA, Kola I. The “gene dosage effect” hypothesis versus the “amplified developmental instability” hypothesis in Down syndrome. J Neural Transm Suppl. 1999;57:293–303.
   PubMedGoogle Scholar
• Delabar JM, Theophile D, Rahmani Z, et al. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet. 1993;1:114–124.
   PubMedGoogle Scholar
• Guidi S, Bonasoni P, Ceccarelli C, et al. Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathol. 2007;18:180–197.
   PubMed Web of Science ®Google Scholar
• Guidi S, Ciani E, Bonasoni P, et al. Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with down syndrome. Brain Pathol. 2011;21:361–373.
   PubMed Web of Science ®Google Scholar
• Briggs JA, Sun J, Shepherd J, et al. Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology. Stem Cells. 2013;31:467–478.
   PubMed Web of Science ®Google Scholar
• Moldrich RX, Dauphinot L, Laffaire J, et al. Proliferation deficits and gene expression dysregulation in Down’s syndrome (Ts1Cje) neural progenitor cells cultured from neurospheres. J Neurosci Res. 2009;87:3143–3152.
   PubMed Web of Science ®Google Scholar
• Hewitt CA, Ling KH, Merson TD, et al. Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome. PLoS One. 2010;5:e11561.
   PubMed Web of Science ®Google Scholar
• Lee HC, Tan KL, Cheah PS, et al. Potential role of JAK-STAT signaling pathway in the neurogenic-to-gliogenic shift in Down Syndrome brain. Neural Plast. 2016;2016:7434191.
   PubMed Web of Science ®Google Scholar
• De-Fraja C, Conti L, Magrassi L, et al. Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain. J Neurosci Res. 1998;54:320–330.
   PubMed Web of Science ®Google Scholar
• De-Fraja C, Conti L, Govoni S, et al. STAT signalling in the mature and aging brain. Int J Dev Neurosci. 2000;18:439–446.
   PubMed Web of Science ®Google Scholar
• Bonni A, Sun Y, Nadal-Vicens M, et al. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science. 1997;278:477–483.
   PubMed Web of Science ®Google Scholar
• Cao F, Hata R, Zhu P, et al. Conditional deletion of Stat3 promotes neurogenesis and inhibits astrogliogenesis in neural stem cells. Biochem Biophys Res Commun. 2010;394:843–847.
   PubMed Web of Science ®Google Scholar
• Kurabayashi N, Nguyen MD, Sanada K. DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model. EMBO Rep. 2015;16:1548–1562.
   PubMed Web of Science ®Google Scholar
• Wilcock DM, Griffin WS. Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis. J Neuroinflammation. 2013;10:84.
   PubMed Web of Science ®Google Scholar
• Sturgeon X, Le T, Ahmed MM, et al. Pathways to cognitive deficits in Down syndrome. Prog Brain Res. 2012;197:73–100.
   PubMed Web of Science ®Google Scholar
• Regis G, Pensa S, Boselli D, et al. Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. Semin Cell Dev Biol. 2008;19:351–359.
   PubMed Web of Science ®Google Scholar
• Tanner DC, Cherry JD, Mayer-Proschel M. Oligodendrocyte progenitors reversibly exit the cell cycle and give rise to astrocytes in response to interferon-gamma. J Neurosci. 2011;31:6235–6246.
   PubMed Web of Science ®Google Scholar
• Sullivan KD, Lewis HC, Hill AA, et al. Trisomy 21 consistently activates the interferon response. eLife. 2016;5:e16220.
   PubMed Web of Science ®Google Scholar
• Guedj F, Pennings JL, Ferres MA, et al. The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome. Am J Med Genet. 2015;167:1993–2008.
   Web of Science ®Google Scholar
• Gomez-Nicola D, Valle-Argos B, Pallas-Bazarra N, et al. Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells. MBoC. 2011;22:1960–1970.
   Google Scholar
• Sago H, Carlson EJ, Smith DJ, et al. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci U S A. 1998;95:6256–6261.
   PubMed Web of Science ®Google Scholar
• Olson LE, Roper RJ, Baxter LL, et al. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev Dyn. 2004;230:581–589.
   PubMed Web of Science ®Google Scholar
• Ling KH, Hewitt CA, Beissbarth T, et al. Molecular networks involved in mouse cerebral corticogenesis and spatio-temporal regulation of Sox4 and Sox11 novel antisense transcripts revealed by transcriptome profiling. Genome Biol. 2009;10:R104.
   PubMed Web of Science ®Google Scholar
• Ling KH, Hewitt CA, Tan KL, et al. Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networks. BMC Genomics. 2014;15:624.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW, Tichopad A, Prgomet C, et al. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper–Excel-based tool using pair-wise correlations. Biotechnol Lett. 2004;26:509–515.
   PubMed Web of Science ®Google Scholar
• Luu-The V, Paquet N, Calvo E, et al. Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques. 2005;38:287–293.
   PubMed Web of Science ®Google Scholar
• Zdaniuk G, Wierzba-Bobrowicz T, Szpak GM, et al. Astroglia disturbances during development of the central nervous system in fetuses with Down’s syndrome. Folia Neuropathol. 2011;49:109–114.
   PubMed Web of Science ®Google Scholar
• Kim YH, Chung JI, Woo HG, et al. Differential regulation of proliferation and differentiation in neural precursor cells by the Jak pathway. Stem Cells. 2010;28:1816–1828.
   PubMed Web of Science ®Google Scholar
• Barry SP, Townsend PA, McCormick J, et al. STAT3 deletion sensitizes cells to oxidative stress. Biochem Biophys Res Commun. 2009;385:324–329.
   PubMed Web of Science ®Google Scholar
• Sriram K, Benkovic SA, Hebert MA, et al. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?. J Biol Chem. 2004;279:19936–19947.
   PubMed Web of Science ®Google Scholar
• Nicolas CS, Peineau S, Amici M, et al. The Jak/STAT pathway is involved in synaptic plasticity. Neuron. 2012;73:374–390.
   PubMed Web of Science ®Google Scholar
• Foshay KM, Gallicano GI. Regulation of Sox2 by STAT3 initiates commitment to the neural precursor cell fate. Stem Cells Dev. 2008;17:269–278.
   PubMed Web of Science ®Google Scholar
• Park SJ, Lee JH, Kim HY, et al. Astrocytes, but not microglia, rapidly sense H(2)O(2)via STAT6 phosphorylation, resulting in cyclooxygenase-2 expression and prostaglandin release. J Immunol. 2012;188:5132–5141.
   PubMed Web of Science ®Google Scholar
• Ferrando-Miguel R, Shim KS, Cheon MS, et al. Overexpression of Interferon α/β receptor β chain in fetal Down syndrome brain. Neuroembryol Aging. 2003;2:147–155.
   Google Scholar
• Amano K, Sago H, Uchikawa C, et al. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Hum Mol Genet. 2004;13:1333–1340.
   PubMed Web of Science ®Google Scholar
• Wilcock DM, Hurban J, Helman AM, et al. Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease. Neurobiol Aging. 2015;36(9):2468–2474.
   PubMed Web of Science ®Google Scholar
• Shukkur EA, Shimohata A, Akagi T, et al. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome. Hum Mol Genet. 2006;15:2752–2762.
   PubMed Web of Science ®Google Scholar
• Chiba T, Yamada M, Sasabe J, et al. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Mol Psychiatry. 2009;14:206–222.
   PubMed Web of Science ®Google Scholar
• Park SJ, Shin EJ, Min SS, et al. Inactivation of JAK2/STAT3 signaling axis and downregulation of M1 mAChR cause cognitive impairment in klotho mutant mice, a genetic model of aging. Neuropsychopharmacol. 2013;38:1426–1437.
   PubMed Web of Science ®Google Scholar
• Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene. 2000;19:2548–2556.
   PubMed Web of Science ®Google Scholar